Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Endo | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Endo

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles A. Rowland, Jr. has been appointed executive vice president, chief financial officer and treasurer, Endo Pharmaceuticals Holdings, Inc. Mr. Rowland has more than 20 years of pharmaceutical industry experience, including senior-level positions at Pharmacia Corp., Novartis, Bristol-Myers Squibb and most recently as senior vice president and chief financial officer of Biovail Pharmaceuticals. In his new role, he will be responsible for all aspects of Endo’s financial and accounting operations, as well as corporate communications.

“We are delighted to welcome an executive of Charlie Rowland’s stature and abilities to Endo’s senior management team,” said Peter A. Lankau, president and chief executive officer. “He brings a successful track record that includes broad-based industry experience, keen financial and transaction acumen and an aligned strategic vision that we believe will benefit us as we enter the next phase of our growth.” Mr. Rowland replaces Endo’s former chief financial officer, Jeff Black, who retired in August.

The company has also promoted David E. Kerr to senior vice president, commercial business, to head the sales and marketing efforts for the both branded and generic businesses.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters